SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

Recent Analyst Ratings for $SGHT

$SGHT SEC Filings

$SGHT Insider Purchases

$SGHT Market Insights

$SGHT Large Ownership Changes

$SGHT Financials

$SGHT Leadership Updates

$SGHT Insider Trading

$SGHT Press Releases

$SGHT Analyst Ratings

Recent Analyst Ratings for
$SGHT

$SGHT
SEC Filings

$SGHT
Insider Purchases

$SGHT
Market Insights

$SGHT
Large Ownership Changes

$SGHT
Financials

$SGHT
Leadership Updates

$SGHT
Insider Trading

$SGHT
Press Releases

$SGHT
Analyst Ratings

Chat with this insight

Sight Sciences Inc. filed SEC Form 8-K: Other Events

Sight Sciences Inc. filed SEC Form 8-K: Other Events

SEC Form 10-Q filed by Sight Sciences Inc.

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Encrantz Staffan bought $497,918 worth of shares (144,000 units at $3.46), increasing direct ownership by 17% to 1,012,150 units (SEC Form 4)

Encrantz Staffan bought $1,760,511 worth of shares (521,855 units at $3.37), increasing direct ownership by 151% to 868,150 units (SEC Form 4)

Encrantz Staffan bought $450,433 worth of shares (188,796 units at $2.39), increasing direct ownership by 120% to 346,295 units (SEC Form 4)

Live Market Insights

Morgan Stanley Maintains Equal-Weight on Sight Sciences, Raises Price Target to $6.5

Citigroup Maintains Neutral on Sight Sciences, Raises Price Target to $6.5

Sight Sciences Announces Publication Of Twelve-Month Results Of SAHARA RCT Data Demonstrating Improved Signs And Symptoms Of Dry Eye Disease For TearCare Patients Crossed Over fFom Restasis

This live feed shows all institutional transactions in real time.

Live finance-specific insights

Live Leadership Updates

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Fastest customizable press release news feed in the world

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

SEC Form SC 13G filed by Sight Sciences Inc.

SEC Form SC 13G/A filed by Sight Sciences Inc. (Amendment)

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

Sight Sciences Appoints Matt Link as Chief Commercial Officer

Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer

Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results

Chief Commercial Officer Link Matthew sold $244,901 worth of shares (42,318 units at $5.79), decreasing direct ownership by 6% to 663,550 units (SEC Form 4)

Chief Commercial Officer Link Matthew sold $244,878 worth of shares (41,704 units at $5.87), decreasing direct ownership by 6% to 705,868 units (SEC Form 4)

President and CEO Badawi Paul sold $76,184 worth of shares (12,727 units at $5.99), decreasing direct ownership by 0.22% to 5,725,433 units (SEC Form 4)

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Lake Street initiated coverage on Sight Sciences with a new price target

Sight Sciences downgraded by BofA Securities with a new price target

Sight Sciences downgraded by Piper Sandler with a new price target

2/14/23 11:01:54 AM ET

$SGHT

Medical/Dental Instruments

Health Care

Get the next $SGHT alert in real time by email

SC 13G/A 1 d417146dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Sight Sciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

82657M105

(CUSIP Number)

December 31, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications:

Evan K. Hall, Esq.

Haynes and Boone, LLP

2323 Victory Avenue, Suite 700

Dallas, Texas 75219

(214) 651-5000

CUSIP No. 82657M105

CUSIP No. 82657M105

CUSIP No. 82657M105

CUSIP No. 82657M105

CUSIP No. 82657M105

CUSIP No. 82657M105

(1)	Includes (i) 86,206, shares of Common Stock held by Mack H. Hicks, as Trustee of the MHH 2016 Descendants Trust, and (ii) 444,588 shares of Common Stock held by MHH Ventures Ltd., which is ultimately owned and controlled by Mack H. Hicks.

(2)	Based upon 48,151,302 shares of Common Stock outstanding as of November 4, 2022, as disclosed in the issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, that was filed by the issuer with the U.S. Securities and Exchange Commission on November 10, 2022.

CUSIP No. 82657M105

Item 1.

(a)

Name of Issuer

Sight Sciences, Inc.

(b)

Address of Issuer’s Principal Executive Offices

4040 Campbell Avenue, Suite 100

Menlo Park, California 94025

Item 2.

(a)

Name of Person Filing

This statement is jointly filed by and on behalf of each of HEP Partners LLC, a Delaware limited liability company (“HEP Partners”), HH Sight LLC, a Texas limited liability company (“HH Sight”), HH Sight Partners GP L.P., a Texas limited partnership (“HH Sight GP”), HH Sight Partners, L.P., a Texas limited partnership (“HH Sight Partners”), HH-IOP Partners, L.P., a Texas limited partnership (“HH-IOP”), Mack H. Hicks, and Thomas O. Hicks (collectively referred to herein as the “Reporting Persons”). Prior to the effective date of this filing, Mack H. Hicks resigned as a director of the issuer, effective January 5, 2023. HH Sight GP is the general partner of, and may be deemed to indirectly beneficially own securities owned by, each of HH Sight Partners and HH-IOP. HH Sight is the general partner of, and may be deemed to indirectly beneficially own securities beneficially owned by, HH Sight GP. Mack H. Hicks and Thomas O. Hicks are the co-managers of, and may each be deemed to indirectly beneficially own securities owned by, HH Sight. HEP Partners is the investment manager of, and may be deemed to indirectly beneficially own securities owned by, each of HH Sight Partners and HH-IOP. Thomas O. Hicks is the Chairman, President, and Chief Executive Officer of, and may be deemed to indirectly beneficially own securities beneficially owned by, HEP Partners. As of December 31, 2022, no other Reporting Person, besides Mack H. Hicks, beneficially owns any security covered by this statement and each Reporting Person disclaims beneficial ownership of any such securities covered by this statement. HEP Partners, HH Sight, HH Sight GP, HH Sight Partners, HH-IOP, and Thomas O. Hicks disclaim beneficial ownership of any securities beneficially owned by Mack H. Hicks, as Trustee of the MHH 2016 Descendants Trust.

Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any group with respect to the issuer or any securities of the issuer.

(b)

Address of Principal Business Office or, if none, Residence

The address of the principal business office of each of the Reporting Persons is c/o HEP Partners LLC, 2200 Ross Avenue, Suite 5000, Dallas, Texas 75201.

(c)

Citizenship

See Item 4 on the cover page(s) hereto.

(d)

Title of Class of Securities

Common Stock, par value $0.001 per share (“Common Stock”).

(e)

CUSIP Number

82657M105

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

(a)

☐ A broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

(b)

☐ A bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

☐ An insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

☐ An investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

☐ An employee benefit plan or endowment fund in accordance with §240.13d- 1(b)(1)(ii)(F);

(g)

☐ A parent holding company or control person in accordance with §240.13d- 1(b)(1)(ii)(G);

(h)

☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment

Company

Act of 1940 (15 U.S.C. 80a-3);

(j)

☐ A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);

(k)

☐ A group, in accordance with §240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________

Item 4.

Ownership

(a)

Amount beneficially owned: See Item 9 on the cover page(s) hereto.

(b)

Percent of class: See Item 11 on the cover page(s) hereto.

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: See Item 5 on the cover page(s) hereto.

(ii)

Shared power to vote or to direct the vote: See Item 6 on the cover page(s) hereto.

(iii)

Sole power to dispose or to direct the disposition of: See Item 7 on the cover page(s) hereto.

(iv)

Shared power to dispose or to direct the disposition of: See Item 8 on the cover page(s) hereto.

Item 5.

Ownership of 5% or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

Item 6.

Ownership of More than 5% on Behalf of Another Person

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not Applicable

Item 8.

Identification and Classification of Members of the Group

Not Applicable

Item 9.

Notice of Dissolution of Group

Not Applicable

Item 10.

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Date: February 14, 2023	HEP PARTNERS LLC

	By:	/s/ Thomas O. Hicks
	Name:	Thomas O. Hicks
	Title:	Managing Member

	HH SIGHT LLC

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

	HH SIGHT PARTNERS GP, L.P.

	By:	HH Sight LLC
	Its:	General Partner

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

	HH SIGHT PARTNERS, L.P.

	By:	HH Sight Partners GP, L.P.
	Its:	General Partner

	By:	HH Sight LLC
	Its:	General Partner

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

	HH-IOP PARTNERS, L.P.

	By:	HH Sight Partners GP, L.P.
	Its:	General Partner

	By:	HH Sight LLC
	Its:	General Partner

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

Thomas O. Hicks

/s/ Thomas O. Hicks

Mack H. Hicks

/s/ Mack H. Hicks

JOINT FILING AGREEMENT

February 14, 2023

Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with the Securities and Exchange Commission (and, if such security is registered on a national securities exchange, also with the exchange), and further agrees to the filing, furnishing, and/or incorporation by reference of this agreement as an exhibit thereto. This agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party.

IN WITNESS WHEREOF, each party hereto, being duly authorized, has caused this agreement to be executed and effective as of the date first written above.


Date: February 14, 2023	HEP PARTNERS LLC

	By:	/s/ Thomas O. Hicks
	Name:	Thomas O. Hicks
	Title:	Managing Member

	HH SIGHT LLC

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

	HH SIGHT PARTNERS GP, L.P.

	By:	HH Sight LLC
	Its:	General Partner

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager

	HH SIGHT PARTNERS, L.P.

	By:	HH Sight Partners GP, L.P.
	Its:	General Partner

	By:	HH Sight LLC
	Its:	General Partner

	By:	/s/ Mack H. Hicks
	Name:	Mack H. Hicks
	Title:	Co-Manager


				HH-IOP PARTNERS, L.P.

				By:		HH Sight Partners GP, L.P.
				Its:		General Partner

				By:		HH Sight LLC
				Its:		General Partner

				By:		/s/ Mack H. Hicks
				Name:		Mack H. Hicks
				Title:		Co-Manager

				Thomas O. Hicks

				/s/ Thomas O. Hicks

				Mack H. Hicks

				/s/ Mack H. Hicks

Get the next $SGHT alert in real time by email

Date	Price Target	Rating	Analyst
8/21/2024	$10.00	Buy	Lake Street
9/12/2023	$10.00 → $4.50	Neutral → Underperform	BofA Securities
9/12/2023	$15.00 → $5.50	Overweight → Neutral	Piper Sandler
9/12/2023		Outperform → Mkt Perform	William Blair
8/24/2023	$12.00 → $8.40	Overweight → Equal-Weight	Morgan Stanley
7/10/2023	$15.00 → $9.00	Buy → Neutral	Citigroup
1/6/2023	$10.00 → $15.00	Hold → Buy	Stifel
10/4/2022		Hold	Needham

Names of Reporting Persons.

HEP Partners LLC

Check the Appropriate Box if a Member of a Group (See Instructions)

(a) ☐ (b) ☑

SEC Use Only

Citizenship or Place of Organization

Delaware